WallStreetZenWallStreetZen

NASDAQ: EDIT
Editas Medicine Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Editas Medicine earnings were -$199.8M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest EDIT earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$25.1M, down 52.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, EDIT reported annual earnings of -$237.1M, with 54.7% growth.

EDIT earnings history

Current Revenue
$46.4M
Current Earnings
-$199.8M
Current Profit Margin
-430.8%

EDIT Return on Equity

Current Company
-348.5%
Current Industry
-21.2%
Current Market
35.1%
EDIT's Return on Equity (-348.5%)... subscribe to Premium to read more.
High Return on Equity Performance

EDIT Return on Assets

Current Company
-78.6%
Current Industry
-8.8%
EDIT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when EDIT announces earnings.

EDIT Return on Capital Employed

Current Company
-143.62%
Current Industry
-3.5%
EDIT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EDIT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
EDIT-$195.18M-$199.84MN/A-$2.38
PRLD-$108.45M-$111.77MN/A-$1.47
ZNTL-$148.62M-$149.32MN/A-$2.07
SGMT-$57.52M-$57.67MN/A-$1.78
KPTI-$149.85M-$196.04MN/A-$17.93
View Top Biotech Stocks

Editas Medicine Earnings Reports & History FAQ

What were Editas Medicine's earnings last quarter?

On EDIT's earnings call on Invalid Date, Editas Medicine (NASDAQ: EDIT) reported Q3 2025 earnings per share (EPS) of -$0.28, up 62.67% year over year. Total EDIT earnings for the quarter were -$25.12 million. In the same quarter last year, Editas Medicine's earnings per share (EPS) was -$0.75.

If you're new to stock investing, here's how to buy Editas Medicine stock.

Is Editas Medicine profitable or losing money?

As of the last Editas Medicine earnings report, Editas Medicine is currently losing money. Editas Medicine's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$199.84 million, a 5.1% decrease year over year.

What was EDIT's earnings growth in the past year?

As of Editas Medicine's earnings date in Invalid Date, Editas Medicine's earnings has grown year over year. EDIT earnings in the past year totalled -$199.84 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.